⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Pneumococcal (Pneumovax)×Pain in extremity

Pain in extremity Reports for Pneumococcal (Pneumovax)

#7 most reported symptom for this vaccine

9,175
Reports
8
Deaths
446
Hospitalizations
0.09
Mortality Rate
%
4.9
Hosp. Rate
%

Pain in extremity and Pneumococcal (Pneumovax)

Pain in extremity has been reported 9,175 times in association with Pneumococcal (Pneumovax) vaccination in VAERS. This represents 12.9% of all 71,157 reports for this vaccine.

Among these reports, 8 mentioned death (0.09%) and 446 involved hospitalization (4.9%).

Pain in extremity is the #7 most frequently reported symptom for Pneumococcal (Pneumovax) out of 2065 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 9,175 reports of Pain in extremity after Pneumococcal (Pneumovax) vaccination may seem alarming, but context is critical.

The mortality rate among these reports is very low at 0.09%, suggesting most cases are non-fatal.

Important Context

Association, not causation: These reports show Pain in extremity occurred after vaccination, not that the vaccine caused it.
Background rates: Pain in extremity may occur naturally at baseline rates in the population, unrelated to vaccination.
Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Quick Facts

Reports:9,175
Deaths:8
Hospitalizations:446
% of Vaccine:12.9%
Rank:#7 of 2065

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.